An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic
NCT ID: NCT04870385
Last Updated: 2021-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2021-04-11
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order
NCT04536441
Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey
NCT04746443
Mindfulness Based Intervention on the COVID-19 Related Distress and Mobile Addiction
NCT05415280
Effects of an Intervention on University Students' Mental Health and Learning During COVID-19
NCT04978194
Effectiveness of an Online Life Skills-based Intervention on Mental Health
NCT05370443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
5-week online prevention program
5-week prevention program
Online modular psychological prevention program featuring integrated elements of Islamic spirituality and Acceptance and Commitment Therapy (ACT).
Control
Waitlist control
Control
Control group waitlisted to receive prevention program after completion of final data collection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5-week prevention program
Online modular psychological prevention program featuring integrated elements of Islamic spirituality and Acceptance and Commitment Therapy (ACT).
Control
Control group waitlisted to receive prevention program after completion of final data collection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-29 years old
* Obtained moderate and above levels in either one of the stress, anxiety, and depression subscales of the DASS-21 pre-intervention assessment
* Muslim
* Owns a gadget with Internet access
* Can read and understand English
Exclusion Criteria
* Those with past or present diagnosis of mental/neurological disorder
* Those reporting active suicidality
* Those involved in any other form of psychological treatment (ie. psychotherapy, pharmacotherapy)
18 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Institute of Islamic Thought
UNKNOWN
International Islamic University Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamilah Hanum Abdul Khaiyom, PhD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamilah Hanum Abdul Khaiyom, PhD
Role: PRINCIPAL_INVESTIGATOR
International Islamic University Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Islamic University Malaysia
Kuala Lumpur, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPI21-052-0052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.